Le Lézard
Classified in: Covid-19 virus
Subject: SVY

Global Cold Flow Improvers Industry (2020 to 2027) - Key Market Trajectory & Analytics


DUBLIN, April 6, 2021 /PRNewswire/ -- The "Cold Flow Improvers - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Amid the COVID-19 crisis, the global market for Cold Flow Improvers estimated at US$ 652.1 Million in the year 2020, is projected to reach a revised size of US$ 954.5 Million by 2027, growing at a CAGR of 5.6% over the analysis period 2020-2027.

Ethylene Vinyl Acetate, one of the segments analyzed in the report, is projected to record a 5.3% CAGR and reach US$ 357.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polyalkyl Methacrylate segment is readjusted to a revised 6.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $175.7 Million, While China is Forecast to Grow at 9.2% CAGR

The Cold Flow Improvers market in the U.S. is estimated at US$ 175.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$ 206.7 Million by the year 2027 trailing a CAGR of 9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Polyalpha Olefin Segment to Record 5.9% CAGR

In the global Polyalpha Olefin segment, USA, Canada, Japan, China and Europe will drive the 5.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$ 98 Million in the year 2020 will reach a projected size of US$ 143.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$ 131.4 Million by the year 2027, while Latin America will expand at a 6.4% CAGR through the analysis period.

Select Competitors (Total 47 Featured):

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/2pnffu

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

19 avr 2024
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...

19 avr 2024
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis. The company's dividend is...

19 avr 2024
Adyton Resources Corporation  ("Adyton" or the "Company") announces it has closed its previously announced non-brokered private placement offering, pursuant to which it has issued 50,000,000 common shares of the Company ("Shares") at a price of...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

19 avr 2024
Lion Group Holding Ltd. ("Lion" or "the Company") , the operator of an all-in-one trading platform that offers a wide spectrum of products and services, today announced that on April 18, 2024, it received a delinquency notification letter from the...

19 avr 2024
Cosmos Health Inc. ("Cosmos Health" or the "Company'') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...



News published on and distributed by: